High-throughput screening of toxicants that modulate extravillous trophoblast migration

Copyright © 2023 Elsevier B.V. All rights reserved..

Migration and subsequent invasion of extravillous trophoblasts into the uterus is essential for proper formation of the placenta. Disruption of these processes may result in poor pregnancy outcomes including preeclampsia, placenta accreta, fetal growth restriction, or fetal death. Currently, there are several methods for quantifying cell migration and invasion in vitro, each with limitations. Therefore, we developed a novel, high-throughput method to screen chemicals for their ability to alter human trophoblast migration. Human HTR8/SVneo trophoblast cells were cultured in Oris™ cell migration plates containing stopper barriers. After EVT cells attached and chemicals were added to media, stoppers were removed thereby creating a cell-free detection zone for migration. Entry of trophoblasts into this zone was monitored through imaging every 6 h and used to calculate a relative cell density. Chemicals known to increase (epidermal growth factor) and decrease (pertussis toxin and cadmium) trophoblast migration were used to validate this in vitro method. Next, a panel of environmental chemicals including bisphenols, mycoestrogens, and flame retardants, were screened for their ability to alter trophoblast invasion. In conclusion, a real-time method to track extravillous trophoblast migration offers potential for screening contaminants as placental toxicants.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:375

Enthalten in:

Toxicology letters - 375(2023) vom: 15. Feb., Seite 1-7

Sprache:

Englisch

Beteiligte Personen:

Meakin, Cassandra [VerfasserIn]
Kim, Christine [VerfasserIn]
Lampert, Thomas [VerfasserIn]
Aleksunes, Lauren M [VerfasserIn]

Links:

Volltext

Themen:

Bisphenol
Cadmium
Extravillous trophoblast
Journal Article
Migration
Placenta
Zearalenone

Anmerkungen:

Date Completed 27.01.2023

Date Revised 16.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.toxlet.2022.12.004

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM350473145